检索结果 - Torsten Zimmermann

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    The Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration (DREAM) study: an open‐label phase II trial

    The Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration (DREAM) study: an open‐label phase II trial 由 Antonia M. Joussen, Sebastián Wolf, Peter K. Kaiser, David S. Boyer, Thomas Schmelter, Rupert Sandbrink, Oliver Zeitz, Gesa Deeg, Annett Richter, Torsten Zimmermann, Joachim Hoechel, Ulf Buetehorn, Walter Schmitt, Brigitte Stemper, Michael Karl Boettger

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106

    In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106 由 Akihiro Takano, Fredrik Piehl, Jan Hillert, Andrea Varrone, Sangram Nag, Balázs Gulyás, Per Stenkrona, Victor L. Villemagne, Christopher C. Rowe, Richard Macdonell, Nabil Al Tawil, Thomas Kucinski, Torsten Zimmermann, Marcus Schultze‐Mosgau, Andrea Thiele, Anja Hoffmann, Christer Halldin

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: